Vimarsana
Biggest News Aggregation in the World

Neuro Solutions News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Neuro Solutions. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Neuro Solutions Today - Breaking & Trending Today

Winners Announced: 2023 Excellence in Healthcare Awards - Vimarsana News

Winners Announced: 2023 Excellence in Healthcare Awards

Honorees included Children's Health CEO Christopher Durovich, Texas Oncology CEO R. Steven Paulson, and Baylor Scott & White Health Clinical Director of the Office of Clinical Ethics and Palliative Care Dr. Robert Fine.

Elekta Expands Market and Treatment Application of Brachytherapy with Acquisition of iCAD, Inc.'s Xoft Business - Vimarsana News

Elekta Expands Market and Treatment Application of Brachytherapy with Acquisition of iCAD, Inc.'s Xoft Business

Clinics and cancer patients to benefit through access to wider range of precise and effective brachytherapy cancer treatment 

Finalists Announced: D CEO's 2023 Excellence in Healthcare Awards - Vimarsana News

Finalists Announced: D CEO's 2023 Excellence in Healthcare Awards

The program recognizes industry leaders and organizations for their industry achievements and impact on the North Texas economy, 

Elekta Esprit Receives Red Dot Design Award for its Focus on Patients and Clinicians - Vimarsana News

Elekta Esprit Receives Red Dot Design Award for its Focus on Patients and Clinicians

Elekta’s latest Leksell Gamma Knife stereotactic radiosurgery (SRS) system, Esprit, wins Red Dot Award 

2023 E&P Meritorious Awards for Engineering Innovation - Vimarsana News

2023 E&P Meritorious Awards for Engineering Innovation

Hart Energy’s Meritorious Awards for Engineering Innovation recognizes 17 technologies for engineering excellence in the upstream petroleum industry and highlights new products and technologies that demonstrate innovation in concept, design and application.